Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FIRY
2451
Firy Inc
FIRY
$152M
| $10.5K | ﹤0.01% |
1,040
-1,040
| -50% | -$19.1K |
|
2452
GeneDx Holdings
WGS
$2.05B
| $7.16K | ﹤0.01% |
797
-846
| -51% | -$18.6K |
|
2453
Albertsons Companies
ACI
$5.63B
| – | – |
-365,676
| Closed | -$9.09M |
|
2454
Ares Capital
ARCC
$13.5B
| – | – |
-210,052
| Closed | -$3.54M |
|
2455
BlackBerry
BB
$4.95B
| – | – |
-98,384
| Closed | -$466K |
|
2456
Bausch Health
BHC
$2.25B
| – | – |
-57,518
| Closed | -$404K |
|
2457
Dutch Bros
BROS
$8.98B
| – | – |
-434,254
| Closed | -$13.5M |
|
|
BBBY
2458
Bed Bath & Beyond
BBBY
$472M
| – | – |
-9,556
| Closed | -$212K |
|
2459
Cardio Diagnostics
CDIO
$4.65M
| – | – |
-6,627
| Closed | -$2M |
|
|
CTLP
2460
DELISTED
Cantaloupe
CTLP
| – | – |
-21,720
| Closed | -$76K |
|
|
DHC
2461
Diversified Healthcare Trust
DHC
$2.17B
| – | – |
-96,776
| Closed | -$94K |
|
2462
HF Sinclair
DINO
$16.7B
| – | – |
-56,436
| Closed | -$3.04M |
|
2463
dLocal
DLO
$4.41B
| – | – |
-52,566
| Closed | -$1.08M |
|
2464
Dianthus Therapeutics
DNTH
$6.16B
| – | – |
-413,612
| Closed | -$9.5M |
|
2465
DoubleVerify
DV
$1.69B
| – | – |
-8,897
| Closed | -$243K |
|
2466
Dyne Therapeutics
DYN
$4.8B
| – | – |
-1,531,906
| Closed | -$19.5M |
|
2467
EyePoint Inc
EYPT
$1.08B
| – | – |
-1,746,868
| Closed | -$13.8M |
|
2468
1-800-Flowers.com
FLWS
$246M
| – | – |
-27,246
| Closed | -$176K |
|
|
FSP
2469
Franklin Street Properties
FSP
$48.1M
| – | – |
-41,308
| Closed | -$110K |
|
|
TDAY
2470
USA Today Co
TDAY
$1.28B
| – | – |
-53,804
| Closed | -$82K |
|
2471
Global E Online
GLBE
$6.7B
| – | – |
-568,866
| Closed | -$15.2M |
|
2472
Health Catalyst
HCAT
$154M
| – | – |
-2,218,438
| Closed | -$21.5M |
|
2473
SeaStar Medical
ICU
$12.7M
| – | – |
-780
| Closed | -$2.01M |
|
2474
Immunic
IMUX
$191M
| – | – |
-62,876
| Closed | -$1.98M |
|
2475
Inseego
INSG
$111M
| – | – |
-3,038
| Closed | -$62K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.